Jane Street’s Opus Genetics IRD Stock Holding History

Jane Street’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$777K	Buy	188,988 +30,885	+20%	+$144K	﹤0.01%	7070
2026 Q1	$719K	Buy	+158,103	New	+$547K	﹤0.01%	7219
2025 Q1	–	Sell	-18,353	Closed	-$21.8K	–	10974
2024 Q4	$21.8K	Buy	+18,353	New	+$21.1K	﹤0.01%	9121
2024 Q3	–	Sell	-42,375	Closed	-$64.8K	–	10595
2024 Q2	$64.8K	Buy	+42,375	New	+$73.2K	﹤0.01%	8864
2024 Q1	–	Sell	-34,691	Closed	-$104K	–	10246
2023 Q4	$104K	Buy	+34,691	New	+$103K	﹤0.01%	8561
2021 Q3	–	Sell	-24,984	Closed	-$132K	–	10895
2021 Q2	$132K	Buy	+24,984	New	+$124K	﹤0.01%	9133
2019 Q1	–	Sell	-277	Closed	-$12K	–	5758
2018 Q4	$12K	Buy	+277	New	+$16.2K	﹤0.01%	4817
2018 Q3	–	Sell	-276	Closed	-$19K	–	5823
2018 Q2	$19K	Buy	+276	New	+$24.3K	﹤0.01%	4869

Other funds holding IRD

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $630M AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street's IRD Position: Q2 2026 in Review

Jane Street increased its Opus Genetics (IRD) stake by 20% in Q2 2026, buying an estimated $144K and bringing the position to 188,988 shares worth $777K. The position accounts for ﹤0.01% of the portfolio, ranked #7070.

Jane Street first reported a position in IRD in Q2 2018 and has held it in 8 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

Jane Street held 188,988 shares of Opus Genetics worth $777K as of Q2 2026.
Jane Street bought 30,885 Opus Genetics shares in Q2 2026, an estimated $144K.
Opus Genetics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7070 holding.
Jane Street first reported a position in Opus Genetics in Q2 2018 and has held it in 8 quarters since.
103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.